221 – 230 of 1952
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Plasma proteomic changes in response to exercise training are associated with cardiorespiratory fitness adaptations
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
(
- Contribution to journal › Letter
-
Mark
Markers of Atrial Myopathy in the General Population : Prevalence, Predictors, and Inter-Relations
(
- Contribution to journal › Article
-
Mark
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease : data from Swedish Heart Failure Registry
(
- Contribution to journal › Article
-
Mark
Bivalirudin Versus Heparin During PCI in NSTEMI : Individual Patient Data Meta-Analysis of Large Randomized Trials
(
- Contribution to journal › Article
-
Mark
Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis
(
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Prognostisk riskstratifiering vid pulmonell arteriell hypertension
(
- Contribution to journal › Article
-
Mark
Genetic insights into resting heart rate and its role in cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI : The time has arrived
(
- Contribution to journal › Debate/Note/Editorial